The legal inquiry focuses on whether officers and directors of the medical device manufacturer prioritized personal interests over their obligations to the company’s stakeholders. Kuehn Law is currently soliciting contact from long-term stockholders to evaluate the scope of the alleged misconduct and assess potential legal remedies.

Interested parties are encouraged to reach out to Sophia Anne Silayan at (833) 672-0814 or via email at ss@kuehnlaw.com. The firm, led by Justin Kuehn, operates on a contingency basis, covering all case costs and providing consultations without upfront fees. Participation is framed by the firm as a mechanism to bolster market integrity, though investors are advised that time constraints may limit the window to pursue formal claims.